Trial intelligence / Profile preview

Intrathecal Nalbuphine vs Fentanyl for Visceral Pain in Cesarean Section

NCT04689217Completed

Sponsor
Cairo University
Start
Jan 2021
Primary completion
Apr 2021
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised trial of nalbuphine in acute pain (3 arms), sponsored by Cairo University. Primary endpoint: Visual Analog Scale for Visceral Abdominal and Shoulder Pain at 30 minutes. Started Jan 2021; status: completed.

02

Drugs

nalbuphine
03

Conditions

acute pain

Beyond the preview

Go deeper on NCT04689217.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04689217.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call